CD8+ CTLs target tumor cells by recognizing specific antigens and secreting cytotoxic substances, while NKT cells link the innate and adaptive immune systems, with type I NKT cells exerting anti-tumor effects and type II NKT cells promoting tumor growth through immunosuppressive actions (5). The gene discussed is CD8A; the disease is neoplasm.